Expression and immune response to hepatitis C virus core DNA–based vaccine constructs
K Tokushige, T Wakita, C Pachuk, D Moradpour, D B Weiner, V R Zurawski, J R Wands – 1 July 1996 – Hepatitis C virus (HCV) is a major worldwide cause of acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. The development of vaccines against HCV have been complicated by the high variability of the envelope region, and it is likely that the cellular immune responses to viral structural proteins may be important for eradicating persistent viral infection.